The inventions described herein relate to devices and associated methods for the treatment of chronic total occlusions. More particularly, the inventions described herein relate to devices and methods for crossing chronic total occlusions and subsequently performing balloon angioplasty, stenting, atherectomy, or other endovascular methods for opening occluded blood vessels.
Due to age, high cholesterol and other contributing factors, a large percentage of the population has arterial atherosclerosis that totally occludes portions of the patient's vasculature and presents significant risks to patient health. For example, in the case of a total occlusion of a coronary artery, the result may be painful angina, loss of cardiac tissue or patient death. In another example, complete occlusion of the femoral and/or popliteal arteries in the leg may result in limb threatening ischemia and limb amputation.
Commonly known endovascular devices and techniques are either inefficient (time consuming procedure), have a high risk of perforating a vessel (poor safety) or fail to cross the occlusion (poor efficacy). Physicians currently have difficulty visualizing the native vessel lumen, cannot accurately direct endovascular devices toward visualized lumen, or fail to advance devices through the lesion. Bypass surgery is often the preferred treatment for patients with chronic total occlusions, but less invasive techniques would be preferred.
To address this and other unmet needs, the present invention provides, in exemplary non-limiting embodiments, devices and methods for the treatment of chronic total occlusions. The disclosed methods and devices are particularly beneficial in crossing coronary total occlusions but may also be useful in other vessels including peripheral arteries and veins. In exemplary embodiments, total occlusions are crossed using methods and devices intended to provide a physician visualization of the occluded vascular lumen or provide physical protection for the wall of the artery to prevent perforation. In additional embodiments, devices and methods are disclosed that enhance the ability to direct and advance a guide wire within the vessel lumen.
In one embodiment, visualization of the occluded segment may be achieved by placing a subintimal device in the space around the area of the lesion. Subintimal device placement may be achieved with a subintimal device directing catheter. The catheter orients a subintimal device so that it passes along the natural delamination plane between intima and media approximating a helical path. The subintimal device directing catheter may be an inflatable balloon catheter having proximal and distal ends with two wire lumens. One lumen accepts a conventional guide wire while the second lumen accepts the subintimal device. In an alternative embodiment, the wire directing catheter may be a guide catheter with distal geometry that steers the subintimal device with the appropriate orientation to enter the subintimal space and advance in a helical pattern around the lesion. Visualization of the artery may be achieved as the subintimal device encircles the artery with each helical turn. The wire's shape may approximate the inside diameter of the lumen and also may define axial bends or tortuosity in the vessel. The subintimal device may further serve the purpose of providing mechanical protection for the artery from perforation or damage from subsequently used devices. Once the subintimal device is in place around the lesion, a number of conventional techniques may be used to cross the lesion including for example stiff guide wires, lasers, ultrasonic energy, mechanical dissection, and atherectomy. Alternatively, a guide wire support device may be used that has the ability to rotationally engage the lesion through helical corkscrew profile on the outside surface. An additional aspect may be the ability to independently steer or direct a guide wire support catheter within the vessel lumen while maintaining the ability to rotate, engage, and advance the corkscrew catheter shaft.
The subintimal device may have a mechanism that rotationally engages the arterial tissues and helps drive the wire through the subintimal space. This mechanism may allow the physician to torque the wire at its proximal end, engage the subintimal tissues and achieve wire advancement. This aspect of the wire may for example include a raised helical corkscrew protrusion on the outside surface of the wire. An additional aspect of the subintimal device may include an atraumatic tip that aids in the prevention of arterial perforation.
It is to be understood that both the foregoing summary and the following detailed description are exemplary. Together with the following detailed description, the drawings illustrate exemplary embodiments and serve to explain certain principles. In the drawings,
The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.
Referring to
An aspect of the disclosure enhances arterial visualization by placing a radiopaque device within the subintimal space around the chronic total occlusion. For the purpose of description, not limitation, the term “subintimal device” will henceforth refer to the wire placed within the subintimal space for purposes of visualization, protecting the vessel, or other purpose, while the term “guide wire” will refer to the wire placed within the vascular lumen for purposes of advancing diagnostic and therapeutic devices within the lumen.
One aspect of the disclosure is the design of the subintimal device. Embodiments of the subintimal device distal tip are described in
In an alternative embodiment,
An additional aspect of the subintimal device is the construction of the device body. The flexibility and torquability of the device body can affect the physician's ability to achieve a helical and subintimal path around the lesion. The sectional view shown in
In an alternative embodiment, a subintimal device body construction is shown in
In another embodiment, the subintimal device body may be constructed in part or in total of a single layer coil with geometric features along the coil length that allow adjacent coils to engage (for example mechanical engagement similar to the teeth of a gear).
Another aspect of the disclosure is the exterior surface of the subintimal device.
An additional aspect of the disclosure may be a device that directs the subintimal device through the intima and into the subintimal space. In one embodiment shown in
An alternative method for achieving subintimal position may use a guide catheter that has distal geometry that directs the device toward the interior vessel wall with the appropriate orientation. An example may be a guide catheter that has a permanently formed curve at the distal end suitable for device advancement. Alternatively, the catheter may be actively steerable so that the physician can choose an orientation insitu.
An additional aspect of the disclosure is the method and devices used to advance devices across the lesion within the vessel lumen. A number of conventional techniques may be used including stiff guide wires, lasers, ultrasonic energy, mechanical dissection, atherectomy and other techniques known to those skilled in the art. One aspect of the disclosure may be a guide wire support device intended to enhance guide wire stiffness, engage the lesion thus providing axial support, and allow the physician to direct the tip of the guide wire.
From the foregoing, it will be apparent to those skilled in the art that the present invention provides, in exemplary non-limiting embodiments, devices and methods for the treatment of chronic total occlusions. Further, those skilled in the art will recognize that the present invention may be manifested in a variety of forms other than the specific embodiments described and contemplated herein. Accordingly, departures in form and detail may be made without departing from the scope and spirit of the present invention as described in the appended claims.
This is a continuation application of application Ser. No. 13/037,797, filed Mar. 1, 2011, which is a continuation of application Ser. No. 11/518,521, filed Sep. 11, 2006, now U.S. Pat. No. 7,918,870, which claims the benefit of U.S. Provisional Application No. 60/716,287, filed Sep. 12, 2005, the contents of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4020829 | Wilson et al. | May 1977 | A |
4233983 | Rocco | Nov 1980 | A |
4569347 | Frisbie | Feb 1986 | A |
4581017 | Sahota | Apr 1986 | A |
4621636 | Fogarty | Nov 1986 | A |
4747821 | Kensey et al. | May 1988 | A |
4762130 | Fogarty et al. | Aug 1988 | A |
4774949 | Fogarty | Oct 1988 | A |
4819634 | Shiber | Apr 1989 | A |
4878495 | Grayzel | Nov 1989 | A |
4976689 | Buchbinder et al. | Dec 1990 | A |
4979939 | Shiber | Dec 1990 | A |
4990134 | Auth | Feb 1991 | A |
5071406 | Jang | Dec 1991 | A |
5127917 | Niderhauser et al. | Jul 1992 | A |
5193546 | Shaknovich | Mar 1993 | A |
5201753 | Lampropoulos et al. | Apr 1993 | A |
5263493 | Avitall | Nov 1993 | A |
5275610 | Eberbach | Jan 1994 | A |
5324263 | Kraus et al. | Jun 1994 | A |
5342301 | Saab | Aug 1994 | A |
5356418 | Shturman | Oct 1994 | A |
5372587 | Hammerslag et al. | Dec 1994 | A |
5383856 | Bersin | Jan 1995 | A |
5385152 | Abele et al. | Jan 1995 | A |
5409453 | Lundquist et al. | Apr 1995 | A |
5415637 | Khosravi | May 1995 | A |
5464395 | Faxon et al. | Nov 1995 | A |
5501667 | Verduin, Jr. | Mar 1996 | A |
5505702 | Arney | Apr 1996 | A |
5534007 | St. Germain et al. | Jul 1996 | A |
5555883 | Avitall | Sep 1996 | A |
5565583 | Frank et al. | Oct 1996 | A |
5571122 | Kelly et al. | Nov 1996 | A |
5571169 | Plaia et al. | Nov 1996 | A |
5603720 | Kieturakis | Feb 1997 | A |
5643298 | Nordgren et al. | Jul 1997 | A |
5645529 | Fagan et al. | Jul 1997 | A |
5655548 | Nelson et al. | Aug 1997 | A |
5669150 | Guertin et al. | Sep 1997 | A |
5695506 | Pike et al. | Dec 1997 | A |
5728133 | Kontos | Mar 1998 | A |
5741270 | Hansen et al. | Apr 1998 | A |
5741429 | Donadio, III et al. | Apr 1998 | A |
5779721 | Nash | Jul 1998 | A |
5807241 | Heimberger | Sep 1998 | A |
5824071 | Nelson et al. | Oct 1998 | A |
5830222 | Makower | Nov 1998 | A |
5830224 | Cohn et al. | Nov 1998 | A |
5843050 | Jones et al. | Dec 1998 | A |
5910133 | Gould | Jun 1999 | A |
5916194 | Jacobsen et al. | Jun 1999 | A |
5935108 | Katoh et al. | Aug 1999 | A |
5944686 | Patterson et al. | Aug 1999 | A |
5954713 | Newman et al. | Sep 1999 | A |
5957900 | Ouchi | Sep 1999 | A |
5968064 | Selmon et al. | Oct 1999 | A |
5989276 | Houser et al. | Nov 1999 | A |
6010449 | Selmon et al. | Jan 2000 | A |
6013055 | Bampos et al. | Jan 2000 | A |
6015405 | Schwartz et al. | Jan 2000 | A |
6022343 | Johnson et al. | Feb 2000 | A |
6036707 | Spaulding | Mar 2000 | A |
6036717 | Mers Kelly et al. | Mar 2000 | A |
6059750 | Fogarty et al. | May 2000 | A |
6068638 | Makower | May 2000 | A |
6071281 | Burnside et al. | Jun 2000 | A |
6071292 | Makower et al. | Jun 2000 | A |
6081738 | Hinohara et al. | Jun 2000 | A |
6099542 | Cohn et al. | Aug 2000 | A |
6117064 | Apple et al. | Sep 2000 | A |
6120516 | Selmon et al. | Sep 2000 | A |
6126649 | VanTassel et al. | Oct 2000 | A |
6155264 | Ressemann et al. | Dec 2000 | A |
6157852 | Selmon et al. | Dec 2000 | A |
6159225 | Makower | Dec 2000 | A |
6183432 | Milo | Feb 2001 | B1 |
6186972 | Nelson et al. | Feb 2001 | B1 |
6190353 | Makower et al. | Feb 2001 | B1 |
6203559 | Davis et al. | Mar 2001 | B1 |
6217527 | Selmon et al. | Apr 2001 | B1 |
6217549 | Selmon et al. | Apr 2001 | B1 |
6221049 | Selmon et al. | Apr 2001 | B1 |
6231546 | Milo et al. | May 2001 | B1 |
6231587 | Makower | May 2001 | B1 |
6235000 | Milo et al. | May 2001 | B1 |
6241667 | Vetter et al. | Jun 2001 | B1 |
6246914 | de la Rama et al. | Jun 2001 | B1 |
6254588 | Jones et al. | Jul 2001 | B1 |
6254598 | Edwards et al. | Jul 2001 | B1 |
6258052 | Milo | Jul 2001 | B1 |
6266550 | Selmon et al. | Jul 2001 | B1 |
6277133 | Kanesaka | Aug 2001 | B1 |
6283940 | Mulholland | Sep 2001 | B1 |
6283951 | Flaherty et al. | Sep 2001 | B1 |
6283983 | Makower et al. | Sep 2001 | B1 |
6287317 | Makower et al. | Sep 2001 | B1 |
6302875 | Makower et al. | Oct 2001 | B1 |
6330884 | Kim | Dec 2001 | B1 |
6337142 | Harder et al. | Jan 2002 | B2 |
6358244 | Newman et al. | Mar 2002 | B1 |
6375615 | Flahery et al. | Apr 2002 | B1 |
6379319 | Garibotto et al. | Apr 2002 | B1 |
6387119 | Wolf et al. | May 2002 | B2 |
6398798 | Selmon et al. | Jun 2002 | B2 |
6416523 | Lafontaine | Jul 2002 | B1 |
6428552 | Sparks | Aug 2002 | B1 |
6432127 | Kim et al. | Aug 2002 | B1 |
6447539 | Nelson et al. | Sep 2002 | B1 |
6475226 | Belef et al. | Nov 2002 | B1 |
6485458 | Takahashi | Nov 2002 | B1 |
6491660 | Guo et al. | Dec 2002 | B2 |
6491707 | Makower et al. | Dec 2002 | B2 |
6506178 | Schubart et al. | Jan 2003 | B1 |
6508824 | Flaherty et al. | Jan 2003 | B1 |
6508825 | Selmon et al. | Jan 2003 | B1 |
6511458 | Milo et al. | Jan 2003 | B2 |
6514217 | Selmon et al. | Feb 2003 | B1 |
6544230 | Flaherty et al. | Apr 2003 | B1 |
6561998 | Roth et al. | May 2003 | B1 |
6565583 | Deaton et al. | May 2003 | B1 |
6569143 | Alchas et al. | May 2003 | B2 |
6569145 | Scmulewitz et al. | May 2003 | B1 |
6579311 | Makower | Jun 2003 | B1 |
6589164 | Flaherty | Jul 2003 | B1 |
6599304 | Selmon et al. | Jul 2003 | B1 |
6602241 | Makower et al. | Aug 2003 | B2 |
6613081 | Kim et al. | Sep 2003 | B2 |
6616675 | Evard et al. | Sep 2003 | B1 |
6623448 | Slater | Sep 2003 | B2 |
6638247 | Selmon et al. | Oct 2003 | B1 |
6638293 | Makower et al. | Oct 2003 | B1 |
6655386 | Makower et al. | Dec 2003 | B1 |
6656195 | Peters et al. | Dec 2003 | B2 |
6660024 | Flaherty et al. | Dec 2003 | B1 |
6669709 | Cohn et al. | Dec 2003 | B1 |
6685648 | Flaherty et al. | Feb 2004 | B2 |
6685716 | Flaherty et al. | Feb 2004 | B1 |
6694983 | Wolf et al. | Feb 2004 | B2 |
6695830 | Vigil et al. | Feb 2004 | B2 |
6709444 | Makower | Mar 2004 | B1 |
6719725 | Milo et al. | Apr 2004 | B2 |
6726677 | Flaherty et al. | Apr 2004 | B1 |
6746426 | Flaherty et al. | Jun 2004 | B1 |
6746462 | Selmon et al. | Jun 2004 | B1 |
6746464 | Makower | Jun 2004 | B1 |
6786884 | DeCant, Jr. et al. | Sep 2004 | B1 |
6800085 | Selmon et al. | Oct 2004 | B2 |
6824550 | Noriega et al. | Nov 2004 | B1 |
6830577 | Nash et al. | Dec 2004 | B2 |
6837868 | Fajnsztajn | Jan 2005 | B1 |
6860892 | Tanaka et al. | Mar 2005 | B1 |
6863684 | Kim et al. | Mar 2005 | B2 |
6866676 | Kieturakis et al. | Mar 2005 | B2 |
6884225 | Kato et al. | Apr 2005 | B2 |
6905505 | Nash et al. | Jun 2005 | B2 |
6929009 | Makower et al. | Aug 2005 | B2 |
6936056 | Nash et al. | Aug 2005 | B2 |
6942641 | Seddon | Sep 2005 | B2 |
6949125 | Robertson | Sep 2005 | B2 |
6991617 | Hektner et al. | Jan 2006 | B2 |
7004173 | Sparks et al. | Feb 2006 | B2 |
7056325 | Makower et al. | Jun 2006 | B1 |
7059330 | Makower | Jun 2006 | B1 |
7083588 | Shmulewitz et al. | Aug 2006 | B1 |
7094230 | Flaherty et al. | Aug 2006 | B2 |
7105031 | Letort | Sep 2006 | B2 |
7134438 | Makeower et al. | Nov 2006 | B2 |
7137990 | Hebert et al. | Nov 2006 | B2 |
7159592 | Makower et al. | Jan 2007 | B1 |
7179270 | Makower | Feb 2007 | B2 |
7191015 | Lamson et al. | Mar 2007 | B2 |
7229421 | Jen et al. | Jun 2007 | B2 |
7316655 | Garibotto et al. | Jan 2008 | B2 |
7377910 | Katoh et al. | May 2008 | B2 |
7413556 | Zhang et al. | Aug 2008 | B2 |
7465286 | Patterson | Dec 2008 | B2 |
20010000041 | Selmon et al. | Mar 2001 | A1 |
20010056273 | C. | Dec 2001 | A1 |
20020029052 | Evans et al. | Mar 2002 | A1 |
20020052637 | Houser et al. | May 2002 | A1 |
20020103459 | Sparks et al. | Aug 2002 | A1 |
20030028200 | Berg et al. | Feb 2003 | A1 |
20030040737 | Merril et al. | Feb 2003 | A1 |
20030109809 | Jen et al. | Jun 2003 | A1 |
20030120195 | Milo et al. | Jun 2003 | A1 |
20030167038 | Yozu et al. | Sep 2003 | A1 |
20030236542 | Makower | Dec 2003 | A1 |
20040015193 | Lamson et al. | Jan 2004 | A1 |
20040059280 | Makower et al. | Mar 2004 | A1 |
20040102719 | Keith et al. | May 2004 | A1 |
20040133225 | Makower | Jul 2004 | A1 |
20040158143 | Flaherty et al. | Aug 2004 | A1 |
20040167554 | Simpson et al. | Aug 2004 | A1 |
20040230156 | Schreck et al. | Nov 2004 | A1 |
20040249277 | Kato et al. | Dec 2004 | A1 |
20040249338 | DeCant, Jr. et al. | Dec 2004 | A1 |
20050038467 | Hebert et al. | Feb 2005 | A1 |
20050049574 | Petrick et al. | Mar 2005 | A1 |
20050171478 | Selmon et al. | Aug 2005 | A1 |
20050177105 | Shalev | Aug 2005 | A1 |
20050216044 | Hong | Sep 2005 | A1 |
20050261663 | Patterson et al. | Nov 2005 | A1 |
20060094930 | Sparks et al. | May 2006 | A1 |
20060135984 | Kramer et al. | Jun 2006 | A1 |
20060229646 | Sparks | Oct 2006 | A1 |
20060271078 | Modesitt | Nov 2006 | A1 |
20070083220 | Shamay | Apr 2007 | A1 |
20070088230 | Terashi et al. | Apr 2007 | A1 |
20070093779 | Kugler et al. | Apr 2007 | A1 |
20070093780 | Kugler et al. | Apr 2007 | A1 |
20070093781 | Kugler et al. | Apr 2007 | A1 |
20070093782 | Kugler et al. | Apr 2007 | A1 |
20070265596 | Jen et al. | Nov 2007 | A1 |
20080103443 | Kabrick et al. | May 2008 | A1 |
20080228171 | Kugler et al. | Sep 2008 | A1 |
20080243065 | Rottenberg et al. | Oct 2008 | A1 |
20080243067 | Rottenberg et al. | Oct 2008 | A1 |
20090088685 | Kugler et al. | Apr 2009 | A1 |
20090124899 | Jacobs et al. | May 2009 | A1 |
20090209910 | Kugler et al. | Aug 2009 | A1 |
20090270890 | Robinson et al. | Oct 2009 | A1 |
20100063534 | Kugler et al. | Mar 2010 | A1 |
20100069945 | Olson et al. | Mar 2010 | A1 |
Number | Date | Country |
---|---|---|
0178822 | Oct 2001 | WO |
2007033052 | Mar 2007 | WO |
2008063621 | May 2008 | WO |
2009054943 | Apr 2009 | WO |
2009100129 | Aug 2009 | WO |
2009134346 | Nov 2009 | WO |
2010019241 | Feb 2010 | WO |
2010044816 | Apr 2010 | WO |
Entry |
---|
Bolia, Amman, “Subintimal Angioplasty: Which Cases To Choose, How to Avoid Pitfalls and Technical Tips.” Combined Session: Vascular Surgery and Interventional Radiology, pp. III 8.1-8.3. |
Columbo, Antonio et al.; “Treating Chronic Total Occlusions Using Subintimal Tracking and Reentry: The Star Technique.” Catheterization and Cardiovascular Interventions, vol. 64: pp. 407-411 (2005). |
International Search Report in PCT/US06/35244 dated Mar. 24, 2008. |
Written Opinion of International Searching Authority in PCT/US06/35244 dated Mar. 24, 2008. |
International Preliminary Report on Patentability in PCT/US06/35244 dated Mar. 17, 2009. |
Office Action for U.S. Appl. No. 11/518,428 dated Jul. 1, 2010. (10 pages). |
Office Action for U.S. Appl. No. 11/518,428 dated Jan. 28, 2010. (15 pages). |
Office Action for U.S. Appl. No. 11/518,428 dated May 29, 2009 (12 pages). |
Number | Date | Country | |
---|---|---|---|
20190247628 A1 | Aug 2019 | US |
Number | Date | Country | |
---|---|---|---|
60716287 | Sep 2005 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13037797 | Mar 2011 | US |
Child | 16396171 | US | |
Parent | 11518521 | Sep 2006 | US |
Child | 13037797 | US |